Overexpression of caldesmon is associated with lymph node metastasis and poorer prognosis in patients with oral cavity squamous cell carcinoma

A previous comparative tissue proteomics study by the authors of the current study led to the identification of caldesmon (CaD) as one of the proteins associated with cervical metastasis of oral cavity squamous cell carcinoma (OSCC). In the current investigation, the authors focused on the potential functions of CaD in patients with OSCC.

[1]  P. Huber.  Caldesmon. , 2020, The international journal of biochemistry & cell biology.

[2]  Ying Liang,et al.  Identification of PRDX4 and P4HA2 as metastasis-associated proteins in oral cavity squamous cell carcinoma by comparative tissue proteomics of microdissected specimens using iTRAQ technology. , 2011, Journal of proteome research.

[3]  C. Köhler.  Histochemical localization of caldesmon isoforms in colon adenocarcinoma and lymph node metastases , 2011, Virchows Archiv.

[4]  N. Wong,et al.  Phosphorylation of Caldesmon by PFTAIRE1 kinase promotes actin binding and formation of stress fibers , 2011, Molecular and Cellular Biochemistry.

[5]  K. Sobue,et al.  Diversification of caldesmon-linked actin cytoskeleton in cell motility , 2011, Cell adhesion & migration.

[6]  Ying Liang,et al.  Overexpression of Activin A in Oral Squamous Cell Carcinoma: Association with Poor Prognosis and Tumor Progression , 2010, Annals of Surgical Oncology.

[7]  Ying Liang,et al.  Enhanced Interferon Signaling Pathway in Oral Cancer Revealed by Quantitative Proteome Analysis of Microdissected Specimens Using 16O/18O Labeling and Integrated Two-dimensional LC-ESI-MALDI Tandem MS* , 2009, Molecular & Cellular Proteomics.

[8]  M. Carrozzo,et al.  Clinical and histopathologic independent prognostic factors in oral squamous cell carcinoma: a retrospective study of 334 cases. , 2008, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[9]  M. Karamouzis,et al.  Head and neck cancer , 2008, The Lancet.

[10]  T. Yen,et al.  Survival in squamous cell carcinoma of the oral cavity , 2007, Cancer.

[11]  Masaru Ushijima,et al.  Identification of a predictive gene expression signature of cervical lymph node metastasis in oral squamous cell carcinoma , 2007, Cancer science.

[12]  J. Kros,et al.  Hela l-CaD Is Implicated in the Migration of Endothelial Cells/Endothelial Progenitor Cells in Human Neoplasms , 2007, Cell adhesion & migration.

[13]  N. Seki,et al.  Gene expression pattern in oral cancer cervical lymph node metastasis. , 2006, Oncology reports.

[14]  Yan Li,et al.  Requirement of reversible caldesmon phosphorylation at P21-activated kinase-responsive sites for lamellipodia extensions during cell migration. , 2006, Cell motility and the cytoskeleton.

[15]  Chih‐Lueh A. Wang,et al.  Phosphorylation of caldesmon during smooth muscle contraction and cell migration or proliferation. , 2006, Journal of biomedical science.

[16]  L. Adam,et al.  Phosphorylated l-caldesmon is involved in disassembly of actin stress fibers and postmitotic spreading. , 2006, Experimental cell research.

[17]  R. Langer,et al.  Association of Pretherapeutic Expression of Chemotherapy-Related Genes with Response to Neoadjuvant Chemotherapy in Barrett Carcinoma , 2005, Clinical Cancer Research.

[18]  W. Hop,et al.  Low-Molecular Weight Caldesmon as a Potential Serum Marker for Glioma , 2005, Clinical Cancer Research.

[19]  A. Carvalho,et al.  Trends in incidence and prognosis for head and neck cancer in the United States: A site‐specific analysis of the SEER database , 2005, International journal of cancer.

[20]  J. Ferlay,et al.  Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.

[21]  Sunil Singhal,et al.  Gene expression signature predicts lymphatic metastasis in squamous cell carcinoma of the oral cavity , 2005, Oncogene.

[22]  J. Kros,et al.  Differential expression of Hela‐type caldesmon in tumour neovascularization: a new marker of angiogenic endothelial cells , 2005, The Journal of pathology.

[23]  I. Jurisica,et al.  Molecular classification of oral cancer by cDNA microarrays identifies overexpressed genes correlated with nodal metastasis , 2004, International journal of cancer.

[24]  Makoto Ohnishi,et al.  Identification of potential biomarkers of lymph node metastasis in oral squamous cell carcinoma by cDNA microarray analysis , 2003, International journal of cancer.

[25]  Jeffrey N Myers,et al.  Disparity in pathologic and clinical lymph node staging in oral tongue carcinoma , 2003, Cancer.

[26]  Marie-France Carlier,et al.  Mechanism of Actin-Based Motility , 2001, Science.

[27]  D. Winn,et al.  Head and neck in situ carcinoma: incidence, trends, and survival. , 2000, Oral oncology.

[28]  D. Helfman,et al.  Caldesmon inhibits nonmuscle cell contractility and interferes with the formation of focal adhesions. , 1999, Molecular biology of the cell.

[29]  K. Sobue,et al.  Genomic structure of the human caldesmon gene. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[30]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[31]  C. L. Wang.  Caldesmon and the regulation of cytoskeletal functions. , 2008, Advances in experimental medicine and biology.

[32]  Y. Yamakita,et al.  Mutant Caldesmon lacking cdc2 phosphorylation sites delays M-phase entry and inhibits cytokinesis. , 2001, Molecular biology of the cell.

[33]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.